ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Phosphatidylcholine:ceramide cholinephosphotransferase 2; EC=2.7.8.27 {ECO:0000269|PubMed:22580896};AltName: Full=Sphingomyelin synthase 2; Short=Sms2; | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
365
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:99680
The FANTOM Consortium and RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group), The Transcriptional Landscape of the Mammalian Genome. Science. 2005;309(5740):1559-1563
J:105120 Huitema K, et al., Identification of a family of animal sphingomyelin synthases. EMBO J. 2004 Jan 14;23(1):33-44 J:164932 Liu J, et al., Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res. 2009 Jul 31;105(3):295-303 J:178175 Li Z, et al., Reducing plasma membrane sphingomyelin increases insulin sensitivity. Mol Cell Biol. 2011 Oct;31(20):4205-18 J:201497 Li Z, et al., Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1577-84 J:220024 Ding T, et al., All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity. J Lipid Res. 2015 Mar;56(3):537-45 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/18/2025 MGI 6.24 |
![]() |
|